Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma

Corresponding Author

Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505 Japan

Institute for Biomedical Sciences Molecular Pathophysiology, Iwate Medical University, Yahaba, Iwate, 028-3694 Japan

Division of Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Iwate, 028-3695 Japan

Corresponding author

Satoshi Serada, PhD, Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, 783-8505, Japan. Tel: +81-88-888-2018, Fax: +81-88-888-2032

E-mail: serada@kochi-u.ac.jp

Tetsuji Naka, MD, PhD, Department of Clinical Immunology, Kochi Medical School, Kochi University, Nankoku, 783-8505, Japan, Tel: +81-88-888-2025, Fax: +81-88-888-2032

E-mail: naka@kochi-u.ac.jp

Search for more papers by this author

Comments (0)

No login
gif